Hello.
How can we help you?

Contactform

Contactform

Comments, compliments or concerns?
We look forward to your feedback.

 
 
Stefan Dudli, PhD
PD Dr.

Stefan Dudli, PhD

Research Group Leader
Languages
German, English

Academic position

Research Group Leader

Specialisation

CRPS
Low back pain

Honors and awards

  • 2022 Best paper award, ISSLS Annual Meeting 2022, Boston, MA, USA
  • 2022 Best paper award, ORS Annual Meeting 2022, Tampa, FL, USA
  • 2019 Travel Award, Annual Meeting European League Against Rheumatism (EULAR)
  • 2017 1st prize of the International Society for the Study of the Lumbar Spine (ISSLS prize) in basic research 2017
  • 2014 Travel Award of the European Society of Biomechanics
  • 2003 Alfred Werner Legat (University of Zurich) for excellent performance in BSc

Academic career

  • Seit 2021 Senior Researcher, Center of Experimental Rheumatology, Balgrist University Hospital and University Hospital Zurich
  • 2016–2021 Postdoc, Center of Experimental Rheumatology, Balgrist University Hospital and University Hospital Zurich
  • 2013–2016 SNSF Postdoctoral Fellow, Department of Ortopaedic Surgery, University of California San Francisco
  • 2013 Postdoc ETH Zurich, Institute for Biomechanics, Switzerland
  • 2009–2013 PhD: ETH Zurich and University of Bern, Institute for Biomechanics, Switzerland
  • 2005–2007 Master in Biochemistry, University of Zurich, Switzerland
  • 2002–2005 Bachelor in Chemistry, University of Zurich, Switzerland

Grants

  • 2023 Gebauer Stiftung "The role of neutrophils in Modic changes in patients with chronic low back pain"
  • 2022–2026 Swiss National Science Foundation (SNSF) “Modic changes in low back pain: unraveling the vicious circle between the intervertebral disc degradome and bone marrow neutrophils”, function: PI
  • 2021–2023 Innovation Pool University Hospital Zurich. “imMODICel – Proof of Concept”, function: PI
  • 2021–2024 FOREUM – Foundation for Research in Rheumatology. Career grant. “The role of the intervertebral disc cartilage catabolites in Modic type 1 changes”, function: PI
  • 2020–2022 NIH Back Pain Consortium (BACPAC). “Blood markers of pathophysiological chronic low back pain phenotypes”, function: sub-contracted PI
  • 2019–2021 Entrepreneur Fellowship in Bio-Tech & Med-Tech, University of Zurich, “Intervening on Low Back Pain Where It Hurts”, function: PI
  • 2019–2021 Center for Applied Biotechnology and Molecular Medicine (CABMM): “Neurotrophism and angiogenesis in Modic type 1 changes”, function: PI
  • 2018–2022 Balgrist Foundation: “Ageing without an aching spine: Biomarkers and treatment of Modic type 1 Changes”, function: PI
  • 2018–2022 VELUX Foundation: “Ageing without an aching spine: Biomarkers to guide treatment of Modic Changes”, function: co-PI
  • 2016–2020 Baugarten Foundation, “The hematopoietic and pro-fibrotic effect of cartilage breakdown products”, function: co-PI
  • 2013–2016 SNFS, PostDoc.Mobility, “Pathobiology of Modic changes”, function: PI

Memberships

  • AOSpine
  • Eurospine
  • Swiss Society for Matrix Biology
  • International Society for the Study of the Lumbar Spine (ISSLS)
  • Center for Applied Biotechnology and Molecular Medicine (CABMM)
  • Orthopaedic Research Society (ORS)
  • ORS Spine Section